Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

HSK GeneTech | ProbioLifeHSK GeneTech | ProbioLife
VS
Syneos HealthSyneos Health
HSK GeneTech | ProbioLife

HSK GeneTech | ProbioLife

121, 11W Biotech Centre 2, Science Park, Sha Tin, 0000, HK

Last Update: 01/12/2025

View Profile
Between 750 and 799
http://www.hskgene.com
750/1000Fair

HSK GeneTech Limited is founded by Professor Kwan Hoi Shan from the Chinese University of Hong Kong and a team of PhD scientists. Professor and the team have had more than 40 years of experience in DNA sequencing and researches in food. Over 10 years of experience in wo...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:6
Subsidiaries:74
12-month incidents
0
Known data breaches
0
Attack type number
0
Syneos Health

Syneos Health

1030 Sync Street, Morrisville, 27560, US

Last Update: 01/04/2026

View Profile
Between 750 and 799
http://www.syneoshealth.com
794/1000Fair

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a ta...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:23,166
Subsidiaries:17
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
HSK GeneTech | ProbioLife

HSK GeneTech | ProbioLife

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Syneos Health

Syneos Health

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for HSK GeneTech | ProbioLife in 2026.

Incidents

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Syneos Health in 2026.

Incidents

Incident History - HSK GeneTech | ProbioLife (X = Date, Y = Severity)

HSK GeneTech | ProbioLife cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Syneos Health (X = Date, Y = Severity)

Syneos Health cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
HSK GeneTech | ProbioLife

HSK GeneTech | ProbioLife

Incidents
No explicit notable incidents reported.
Syneos Health

Syneos Health

Incidents
No explicit notable incidents reported.

FAQ

Between HSK GeneTech | ProbioLife company and Syneos Health company, which one has the best AI Cybersecurity Score ?
Between HSK GeneTech | ProbioLife company and Syneos Health company, which one has experienced more cyber incidents in the past ?
Between HSK GeneTech | ProbioLife company and Syneos Health company, which one has experienced more cyber incidents this year ?
Between HSK GeneTech | ProbioLife company and Syneos Health company, which one has experienced at least one ransomware attack ?
Between HSK GeneTech | ProbioLife company and Syneos Health company, which one has experienced at least one data breach ?
Between HSK GeneTech | ProbioLife company and Syneos Health company, which one has experienced at least one targeted cyberattack ?
Between HSK GeneTech | ProbioLife company and Syneos Health company, which one has experienced at least one vulnerability ?
Between HSK GeneTech | ProbioLife company and Syneos Health company, which one holds the most compliance certifications ?
Between HSK GeneTech | ProbioLife company and Syneos Health company, which one holds the fewest compliance certifications ?
Between HSK GeneTech | ProbioLife company and Syneos Health company, which one has the most subsidiaries ?
Between HSK GeneTech | ProbioLife company and Syneos Health company, which one has the largest number of employees ?
Between HSK GeneTech | ProbioLife and Syneos Health, which company holds both SOC 2 Type 1 certifications ?
Between HSK GeneTech | ProbioLife and Syneos Health, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - HSK GeneTech | ProbioLife or Syneos Health ?
Which company is PCI DSS compliant - HSK GeneTech | ProbioLife or Syneos Health ?
Between HSK GeneTech | ProbioLife and Syneos Health, which company complies with HIPAA regulations for healthcare data ?
Between HSK GeneTech | ProbioLife and Syneos Health, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-61246
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-60455
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-60439
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-60373
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-60372
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 9.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 9.8)
CVSS3
Base Score: 9.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
3.9